Cargando…
CBD-oil as a potential solution in case of severe tamoxifen-related side effects
Tamoxifen may lead to bothersome side effects contributing to non-compliance and decreased quality of life. Patients searching for relief are increasingly turning to cannabinoids such as CBD-oil. However, CBD-oil might affect tamoxifen pharmacokinetics (PK) through CYP2D6 inhibition. The aims of thi...
Autores principales: | Buijs, Sanne M., Braal, C. Louwrens, Buck, Stefan A. J., van Maanen, Noud F., van der Meijden-Erkelens, Lonneke M., Kuijper-Tissot van Patot, Heleen A., Hoop, Esther Oomen-de, Saes, Lotte, van den Boogerd, Sophia J., Struik, Liesbeth E. M., van Rossum-Schornagel, Quirine C., Mathijssen, Ron H. J., Koolen, Stijn L. W., Jager, Agnes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404290/ https://www.ncbi.nlm.nih.gov/pubmed/37543688 http://dx.doi.org/10.1038/s41523-023-00570-x |
Ejemplares similares
-
Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer
por: Braal, C. Louwrens, et al.
Publicado: (2021) -
The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer
por: Buijs, S.M., et al.
Publicado: (2023) -
Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment
por: Buck, Stefan A. J., et al.
Publicado: (2022) -
Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial
por: Braal, C. Louwrens, et al.
Publicado: (2022) -
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen
por: Braal, C. Louwrens, et al.
Publicado: (2020)